Hospitalized primary headache in children after emergency department evaluation: a retrospective cohort study.

IF 2 4区 医学 Q3 CLINICAL NEUROLOGY
Miguel Ángel Molina Gutiérrez, Natalia Alfaro León, Miguel Ángel Fernández-García, Begoña de Miguel Lavisier, María de Ceano-Vivas La Calle
{"title":"Hospitalized primary headache in children after emergency department evaluation: a retrospective cohort study.","authors":"Miguel Ángel Molina Gutiérrez, Natalia Alfaro León, Miguel Ángel Fernández-García, Begoña de Miguel Lavisier, María de Ceano-Vivas La Calle","doi":"10.1007/s13760-026-03205-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To characterize the clinical features, diagnostic evaluation, management, and final diagnoses of children hospitalized for headache following emergency department (ED) evaluation, and to explore factors associated with treatment refractoriness.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of children aged 4-17 years presenting to a tertiary pediatric ED with headache as the primary complaint who required hospitalization between January 2019 and June 2024. Patients whose headache was clearly attributed to trauma, fever, or a previously identified systemic or neurological disorder were excluded. Final headache diagnoses were established during hospitalization by the pediatric neurology team, using ICHD-3 criteria when applicable. Data included demographics, clinical presentation, diagnostic testing, treatments, and discharge diagnoses. Descriptive analyses were performed, with exploratory comparisons between patients requiring ≤ 2 versus > 2 sequential pharmacologic interventions.</p><p><strong>Results: </strong>Among 3,646 ED visits for headache, 162 (4.4%) resulted in hospitalization; 30 children (18.5% of admissions) had a final diagnosis of primary headache and constituted the study cohort. Mean age was 12.7 years, and 70.0% were female. Although frontal location and pressure-type pain were the most common presentation features, 76.7% of patients were ultimately diagnosed with migraine or probable migraine. Acute neurological abnormalities were documented in 10.0% of patients. Cranial CT was performed in 63.3% and brain MRI in 23.3%, with no acute intracranial abnormality or secondary cause explaining the headache identified. Intravenous metamizole (dipyrone) was the most frequently used first-line acute therapy, and 70.0% of patients required a second sequential pharmacologic intervention. Among patients diagnosed with migraine or probable migraine, 21.7% met criteria for status migrainosus. No clinical variables were significantly associated with treatment refractoriness.</p><p><strong>Conclusions: </strong>Hospitalization for primary headache after pediatric ED evaluation was uncommon but identified a clinically severe subgroup, predominantly with migraine-spectrum disorders and frequently requiring escalation of acute treatment. Despite frequent neuroimaging, no acute intracranial abnormality or secondary cause explaining the headache was identified. These findings suggest that more selective imaging strategies may be appropriate in children with a reassuring clinical presentation, although prospective studies are needed to better define predictors of hospitalization, treatment refractoriness, and optimal acute management.</p>","PeriodicalId":7042,"journal":{"name":"Acta neurologica Belgica","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta neurologica Belgica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13760-026-03205-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To characterize the clinical features, diagnostic evaluation, management, and final diagnoses of children hospitalized for headache following emergency department (ED) evaluation, and to explore factors associated with treatment refractoriness.

Methods: We conducted a retrospective cohort study of children aged 4-17 years presenting to a tertiary pediatric ED with headache as the primary complaint who required hospitalization between January 2019 and June 2024. Patients whose headache was clearly attributed to trauma, fever, or a previously identified systemic or neurological disorder were excluded. Final headache diagnoses were established during hospitalization by the pediatric neurology team, using ICHD-3 criteria when applicable. Data included demographics, clinical presentation, diagnostic testing, treatments, and discharge diagnoses. Descriptive analyses were performed, with exploratory comparisons between patients requiring ≤ 2 versus > 2 sequential pharmacologic interventions.

Results: Among 3,646 ED visits for headache, 162 (4.4%) resulted in hospitalization; 30 children (18.5% of admissions) had a final diagnosis of primary headache and constituted the study cohort. Mean age was 12.7 years, and 70.0% were female. Although frontal location and pressure-type pain were the most common presentation features, 76.7% of patients were ultimately diagnosed with migraine or probable migraine. Acute neurological abnormalities were documented in 10.0% of patients. Cranial CT was performed in 63.3% and brain MRI in 23.3%, with no acute intracranial abnormality or secondary cause explaining the headache identified. Intravenous metamizole (dipyrone) was the most frequently used first-line acute therapy, and 70.0% of patients required a second sequential pharmacologic intervention. Among patients diagnosed with migraine or probable migraine, 21.7% met criteria for status migrainosus. No clinical variables were significantly associated with treatment refractoriness.

Conclusions: Hospitalization for primary headache after pediatric ED evaluation was uncommon but identified a clinically severe subgroup, predominantly with migraine-spectrum disorders and frequently requiring escalation of acute treatment. Despite frequent neuroimaging, no acute intracranial abnormality or secondary cause explaining the headache was identified. These findings suggest that more selective imaging strategies may be appropriate in children with a reassuring clinical presentation, although prospective studies are needed to better define predictors of hospitalization, treatment refractoriness, and optimal acute management.

急诊评估后住院儿童原发性头痛:一项回顾性队列研究。
目的:探讨急诊(ED)评估后住院儿童头痛的临床特征、诊断评价、处理和最终诊断,并探讨治疗难治性的相关因素。方法:我们对2019年1月至2024年6月期间以头痛为主诉就诊于第三儿科急诊科的4-17岁儿童进行了一项回顾性队列研究。头痛明显归因于创伤、发热或先前确定的系统性或神经系统疾病的患者被排除在外。最终的头痛诊断由儿科神经内科团队在住院期间确定,适用时使用ICHD-3标准。数据包括人口统计、临床表现、诊断测试、治疗和出院诊断。进行描述性分析,探索性比较需要≤2和> 2顺序药物干预的患者。结果:在因头痛就诊的3,646例患者中,162例(4.4%)最终住院;30名儿童(占入院人数的18.5%)最终诊断为原发性头痛,构成研究队列。平均年龄12.7岁,70.0%为女性。虽然额部定位和压力型疼痛是最常见的表现特征,但76.7%的患者最终被诊断为偏头痛或可能的偏头痛。10.0%的患者出现急性神经系统异常。颅脑CT检查占63.3%,颅脑MRI检查占23.3%,未发现急性颅内异常或继发原因。静脉注射安美唑(双吡隆)是最常用的一线急性治疗方法,70.0%的患者需要第二次顺序药物干预。在诊断为偏头痛或可能偏头痛的患者中,21.7%符合偏头痛状态的标准。没有临床变量与治疗难治性显著相关。结论:儿童ED评估后因原发性头痛住院治疗并不常见,但确定了一个临床严重的亚组,主要是偏头痛谱系障碍,经常需要急性治疗升级。尽管经常进行神经影像学检查,但没有发现急性颅内异常或继发原因可以解释头痛。尽管需要前瞻性研究来更好地确定住院、治疗难治性和最佳急性治疗的预测因素,但这些发现表明,对于临床表现令人放心的儿童,更有选择性的影像学策略可能是合适的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta neurologica Belgica
Acta neurologica Belgica 医学-临床神经学
CiteScore
4.20
自引率
3.70%
发文量
300
审稿时长
6-12 weeks
期刊介绍: Peer-reviewed and published quarterly, Acta Neurologica Belgicapresents original articles in the clinical and basic neurosciences, and also reports the proceedings and the abstracts of the scientific meetings of the different partner societies. The contents include commentaries, editorials, review articles, case reports, neuro-images of interest, book reviews and letters to the editor. Acta Neurologica Belgica is the official journal of the following national societies: Belgian Neurological Society Belgian Society for Neuroscience Belgian Society of Clinical Neurophysiology Belgian Pediatric Neurology Society Belgian Study Group of Multiple Sclerosis Belgian Stroke Council Belgian Headache Society Belgian Study Group of Neuropathology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书